Nifty
Sensex
:
:
10682.20
35457.16
65.50 (0.62%)
196.62 (0.56%)

Chemicals

Rating :
74/99

BSE: 530019 | NSE: JUBILANT

753.10
-0.40 (-0.05%)
16-Nov-2018 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  757.60
  •  757.60
  •  746.00
  •  753.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  113297
  •  853.24
  •  1039.00
  •  586.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,974.76
  • 15.35
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 15,194.85
  • 0.40%
  • 2.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.42%
  • 11.91%
  • FII
  • DII
  • Others
  • 0.08%
  • 4.34%
  • 29.57%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.89
  • 5.31
  • 9.35

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.31
  • 8.26
  • 4.02

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.54
  • 42.59
  • 17.94

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.96
  • 18.51
  • 19.52

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.79
  • 2.14
  • 2.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.66
  • 9.38
  • 10.19

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Net Sales
2,269.49
1,642.04
38.21%
2,078.65
1,596.05
30.24%
2,251.96
1,641.42
37.20%
2,067.76
1,491.64
38.62%
Expenses
1,819.31
1,335.98
36.18%
1,641.05
1,258.44
30.40%
1,794.09
1,336.44
34.24%
1,650.92
1,159.82
42.34%
EBITDA
450.18
306.06
47.09%
437.60
337.61
29.62%
457.87
304.98
50.13%
416.84
331.82
25.62%
EBIDTM
19.84%
18.64%
21.05%
21.15%
20.33%
18.58%
20.16%
22.25%
Other Income
3.83
7.09
-45.98%
9.47
6.81
39.06%
22.91
10.53
117.57%
3.22
5.12
-37.11%
Interest
62.72
66.01
-4.98%
72.70
68.73
5.78%
72.48
80.19
-9.61%
77.06
98.19
-21.52%
Depreciation
89.48
79.01
13.25%
88.00
72.48
21.41%
181.74
75.22
141.61%
81.82
72.65
12.62%
PBT
301.81
168.13
79.51%
286.37
203.21
40.92%
226.56
160.10
41.51%
261.18
166.10
57.24%
Tax
92.04
42.66
115.75%
86.00
59.50
44.54%
74.16
11.07
569.92%
48.34
47.99
0.73%
PAT
209.77
125.47
67.19%
200.37
143.71
39.43%
152.40
149.03
2.26%
212.84
118.11
80.20%
PATM
9.24%
7.64%
9.64%
9.00%
6.77%
9.08%
10.29%
7.92%
EPS
13.51
8.24
63.96%
13.00
9.45
37.57%
9.94
9.64
3.11%
13.64
7.67
77.84%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
8,667.86
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
3,791.13
3,517.98
Net Sales Growth
36.05%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
-9.11%
7.76%
 
Cost Of Goods Sold
3,351.01
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
1,471.11
1,352.42
Gross Profit
5,316.85
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
2,320.02
2,165.57
GP Margin
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
61.20%
61.56%
Total Expenditure
6,905.37
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
3,111.07
2,834.73
Power & Fuel Cost
-
424.91
333.66
366.71
393.04
389.74
356.73
286.89
224.04
220.03
197.91
% Of Sales
-
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
5.80%
5.63%
Employee Cost
-
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
735.21
648.49
% Of Sales
-
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
19.39%
18.43%
Manufacturing Exp.
-
485.98
428.84
436.46
432.40
405.14
360.48
329.75
284.66
315.90
293.91
% Of Sales
-
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
8.33%
8.35%
General & Admin Exp.
-
365.54
280.98
256.23
302.28
264.23
208.35
200.72
195.72
196.68
191.38
% Of Sales
-
4.86%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
5.19%
5.44%
Selling & Distn. Exp.
-
247.85
185.79
135.54
203.98
160.04
123.28
111.85
90.92
125.97
124.22
% Of Sales
-
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
3.32%
3.53%
Miscellaneous Exp.
-
56.78
53.20
65.96
39.72
19.59
23.53
28.50
27.21
46.18
124.22
% Of Sales
-
0.76%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
1.22%
0.75%
EBITDA
1,762.49
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
680.06
683.25
EBITDA Margin
20.33%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
17.94%
19.42%
Other Income
39.43
40.03
24.86
13.37
42.45
19.06
29.87
31.48
17.24
118.09
106.66
Interest
284.96
284.28
341.11
371.35
367.61
337.11
310.93
238.23
119.99
155.57
330.09
Depreciation
441.04
415.05
291.40
346.74
287.95
281.17
253.79
220.65
180.10
124.68
163.24
PBT
1,075.92
859.08
737.64
542.22
88.43
421.78
533.29
462.79
282.02
517.90
296.58
Tax
300.54
224.66
163.02
155.40
80.48
69.64
152.36
68.41
13.37
95.94
26.72
Tax Rate
27.93%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
18.52%
9.01%
PAT
775.38
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
421.46
283.18
PAT before Minority Interest
780.32
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
421.95
269.86
Minority Interest
4.94
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
-0.49
13.32
PAT Margin
8.95%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
11.12%
8.05%
PAT Growth
44.57%
11.66%
46.92%
-
-
-28.61%
948.97%
-93.66%
-45.49%
48.83%
 
Unadjusted EPS
50.09
41.25
36.93
25.10
-3.63
6.85
9.59
0.91
14.42
28.56
19.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
2,201.34
1,542.64
Share Capital
15.58
15.57
15.54
15.93
15.45
15.93
15.93
15.93
15.88
14.76
Total Reserves
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
2,185.46
1,527.89
Non-Current Liabilities
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
3,365.15
4,056.86
Secured Loans
1,109.17
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
2,160.79
2,966.30
Unsecured Loans
1,938.64
1,923.07
392.79
375.00
0.22
760.06
0.45
400.61
1,011.94
975.49
Long Term Provisions
107.08
80.69
70.31
67.04
219.53
237.96
169.70
39.87
0.00
0.00
Current Liabilities
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
1,220.11
1,130.63
Trade Payables
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
517.43
688.83
584.06
Other Current Liabilities
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
64.70
88.72
Short Term Borrowings
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
0.00
0.00
Short Term Provisions
117.81
106.24
151.93
97.49
257.25
101.84
109.18
403.28
466.59
457.85
Total Liabilities
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.52
6,762.08
Net Block
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
3,818.89
3,745.00
Gross Block
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
4,845.26
4,648.26
Accumulated Depreciation
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
1,026.38
903.26
Non Current Assets
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
4,357.21
4,281.34
Capital Work in Progress
670.97
683.78
611.32
596.60
472.39
436.89
685.55
666.71
505.63
503.12
Non Current Investment
123.52
102.71
85.43
39.50
33.99
25.61
19.20
32.75
32.70
33.22
Long Term Loans & Adv.
71.79
56.32
62.67
327.17
328.42
379.47
299.86
249.18
0.00
0.00
Other Non Current Assets
0.58
1.08
0.53
29.68
2.21
0.37
0.79
0.55
0.00
0.00
Current Assets
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
2,455.22
2,205.31
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
223.71
238.13
Inventories
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
690.95
595.61
Sundry Debtors
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
518.61
504.41
Cash & Bank
248.79
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
503.67
381.66
Other Current Assets
418.81
225.73
244.07
121.03
301.21
380.29
357.59
334.88
518.27
485.49
Short Term Loans & Adv.
45.75
37.06
133.06
144.56
136.04
182.01
256.70
217.50
498.14
444.09
Net Current Assets
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
322.08
1,235.11
1,074.69
Total Assets
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
6,824.51
6,762.08

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
709.61
558.06
PBT
859.08
737.64
542.22
40.32
207.28
341.14
114.11
240.59
517.90
296.58
Adjustment
687.81
637.90
737.89
725.84
756.60
752.36
795.44
318.42
189.22
352.94
Changes in Working Capital
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
62.58
-55.56
Cash after chg. in Working capital
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
769.70
593.96
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
-60.57
-41.99
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
-279.75
-2,030.73
Net Fixed Assets
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
-128.63
-492.68
Net Investments
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
-159.67
-331.27
Others
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
8.55
-1,206.78
Cash from Financing Activity
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
-298.02
1,150.66
Net Cash Inflow / Outflow
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
131.84
-322.01
Opening Cash & Equivalents
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
381.66
523.77
Closing Cash & Equivalent
244.18
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15
505.34
375.89

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
262.33
220.61
190.90
154.04
170.07
155.46
141.70
136.38
137.88
85.89
ROA
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
6.21%
4.93%
ROE
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
24.42%
21.40%
ROCE
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
12.74%
14.62%
Fixed Asset Turnover
1.26
1.09
0.92
0.81
0.84
0.82
0.78
0.70
0.82
1.02
Receivable days
51.58
59.43
54.81
49.56
46.53
47.00
48.71
53.83
48.18
46.63
Inventory Days
63.07
73.64
75.51
78.58
75.51
73.76
71.07
71.61
60.59
51.66
Payable days
56.86
54.84
53.44
52.17
51.42
45.33
38.70
50.95
58.42
49.77
Cash Conversion Cycle
57.79
78.23
76.88
75.98
70.61
75.42
81.08
74.50
50.34
48.52
Total Debt/Equity
0.85
1.18
1.51
1.95
1.67
1.71
1.69
1.81
1.45
3.11
Interest Cover
4.02
3.16
2.46
1.11
1.61
2.10
1.48
3.01
4.33
1.90

Annual Reports:

News Update:


  • Jubilant Life Sciences reports 64% rise in Q2 consolidated net profit
    22nd Oct 2018, 15:05 PM

    Total consolidated income of the company increased by 37.85% at Rs 2,273.32 crore for Q2FY19

    Read More
  • Jubilant LifeScience - Quarterly Results
    22nd Oct 2018, 14:42 PM

    Read More
  • Jubilant Life Sciences raises Rs 350 crore via NCDs
    6th Sep 2018, 10:12 AM

    The company has issued 3,500 NCDs of Rs 10 lakh each for cash at par on September 5, 2018

    Read More
  • Ind-Ra upgrades long term credit rating of Jubilant Life Sciences
    24th Aug 2018, 11:52 AM

    The rating agency has also affirmed the company’s short term credit rating of ‘A1+’

    Read More
  • Jubilant Life Sciences earmarks Rs 550 crore capital expenditure in FY19
    20th Aug 2018, 10:45 AM

    The company will continue its efforts to strengthen its balance sheet by improving financial ratios and reducing debt

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.